Author:
Hendrix Craig W,Collier Ann C,Lederman Michael M,Schols Dominique,Pollard Richard B,Brown Stephen,Jackson J Brooks,Coombs Robert W,Glesby Marshall J,Flexner Charles W,Bridger Gary J,Badel Karin,MacFarland Ronald T,Henson Geoffrey W,Calandra Gary
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Infectious Diseases
Reference43 articles.
1. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.;Yeni;JAMA,2002
2. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.;Berger;Annu Rev Immunol,1999
3. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.;Kilby;Nat Med,1998
4. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.;Lalezari;Antivir Ther,2003
5. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.;Lalezari;N Engl J Med,2003
Cited by
321 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献